HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ribosomal protein L39

Networked: 9 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Ribosomal Proteins: 1138
    - ribosomal protein L39: 9

Experts

1.	Chang, Jenny C: 3 articles (11/2019 - 06/2014)
2.	Dave, Bhuvanesh: 3 articles (11/2019 - 06/2014)
3.	Ensor, Joe E: 2 articles (11/2019 - 01/2017)
4.	Mills, Gordon B: 2 articles (11/2019 - 01/2017)
5.	Wong, Helen: 2 articles (11/2019 - 01/2017)
6.	Gross, Steven S: 2 articles (01/2017 - 06/2014)
7.	Li, Xiaoxian: 2 articles (01/2017 - 06/2014)
8.	He, Y J: 1 article (07/2021)
9.	Jiang, M X: 1 article (07/2021)
10.	Lin, T T: 1 article (07/2021)

Related Diseases

1.	Pancreatic Neoplasms (Pancreatic Cancer) 05/01/2014 - "Our previous studies showed that the ribosomal protein L39 (RPL39) gene was up-regulated after long-term silencing of oncogenic KRAS in pancreatic cancer PANC-1 cells, which indicated that RPL39 may be important for pancreatic cancer development and survival. " 05/01/2014 - "Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo."
2.	Neoplasms (Cancer) 09/27/2002 - "A human gene encoding a protein homologous to ribosomal protein L39 is normally expressed in the testis and derepressed in multiple cancer cells." 01/01/2021 - "Ribosomal protein L39 (RPL39) is a member of the S39E family of ribosomal proteins that plays an important role in stem cell self-renewal, cancer metastasis, and chemoresistance. "
3.	Myeloid Leukemia (Leukemia, Myelocytic) 11/01/2019 - "We have previously shown that hematological and neurological expressed 1-like (HN1L), ribosomal protein L39 (RPL39), and myeloid leukemia factor 2 (MLF2) are novel targets for BCSC self-renewal, and targeting these genetic alterations could be useful for personalized genomic-based therapy. " 06/17/2014 - "Selective shRNA knockdown identified ribosomal protein L39 (RPL39) and myeloid leukemia factor 2 (MLF2) as the top candidates that affect BCSC self-renewal. "
4.	Triple Negative Breast Neoplasms 01/01/2017 - "We have previously demonstrated that ribosomal protein L39 (RPL39) and its gain-of-function mutation A14V have oncogenic activity in triple-negative breast cancer and this activity may be mediated through inducible nitric oxide synthase (iNOS). "
5.	Pre-Eclampsia (Preeclampsia) 01/01/2021 - "Downregulated ribosomal protein L39 inhibits trophoblast cell migration and invasion by targeting E-cadherin in the placenta of patients with preeclampsia."

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)
2.	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
3.	Adenosylhomocysteinase
4.	Small Interfering RNA (siRNA)
5.	Complementary DNA (cDNA)
6.	Cadherins (E-Cadherin)
7.	Ribosomal Proteins (Ribosomal Protein)
8.	Hemoglobins (Hemoglobin)
9.	Collagen
10.	Acids

Related Therapies and Procedures

1.	Therapeutics